Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 54

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 54
---

  
    Interest on lease liabilities - finance lease 
     13,081  
     23,550 
  
    Operating lease cost 
     29,793  
     29,915 
  
    Total lease cost 
    $139,117  
    $149,708 

    Cash paid for amounts included in the measurement of lease liabilities: 

    Operating cash flows from finance leases 
    $100,266  
    $88,665 
  
    Operating cash flows from operating leases 
     29,197  
     30,431 

SCHEDULE OF BALANCE SHEET INFORMATION RELATING TO LEASES

    Operating leases: 
    March 31, 2025  
    December 31, 2024 
  
    Operating lease right-of-use, assets 
    $431,746  
    $463,011 
  
    Operating lease liability, current 
    $130,342  
    $127,498 
  
    Operating lease liability, non-current 
    $308,415  
    $342,098 
  
    Total operating lease liabilities 
    $438,757  
    $469,596 

    Finance leases: 
    March 31, 2025  
    December 31, 2024 
  
    Finance lease right-of-use asset, gross 
    $1,294,168  
    $1,294,168 
  
    Accumulated amortization 
     (609,539) 
     (513,296)
  
    Finance lease right-of-use asset, net 
    $684,629  
    $780,872 
  
    Finance lease liability, current portion 
    $403,584  
    $395,301 
  
    Finance lease liability, long-term 
     335,899  
     444,448 
  
    Total finance lease liabilities 
    $739,483  
    $839,749 

    Weighted-average remaining lease term: 
    March 31, 2025  
    December 31, 2024 
  
    Operating leases (in years) 
     3.60  
     4.21 
  
    Finance leases (in years) 
     2.28  
     2.39 

    Weighted-average discount rate: 
    March 31, 2025  
    December 31, 2024